Spherix (NASDAQ:SPEX)
announces the execution of an exclusive option agreement with UMBC for
the technology in the patent for “Methods of Treating Coronavirus
Infection.”
Shares of the nano-cap are higher by 37% to $0.97.
Volume is already at 7.7M vs. average daily volume of just over 1M.
Source: Press Release
https://seekingalpha.com/news/3549430-spherix-soars-on-coronavirus-treatment-deal
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.